SEC Form 4 · accession 0001437749-16-034203
Protagenic Therapeutics, Inc.\new · PTIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander K. Arrow
Officer — Chief Financial Officer
Period of report
Jun 17, 2016
Accepted (ET)
Jun 21, 2016 · 9:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| NSO Stock OptionF1 | Jun 17, 2016 | A | 140,000 | $1.25 | A | 358,260 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Dollar figure listed indicates exercise price of the stock option grant.